Results of a study examining chemoimmunotherapy regimen R-CHOP in combination with an engineered tumor necrosis factor to enhance treatment of primary central nervous system lymphoma.
Home / Resource Library / R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-? in primary CNS lymphoma